Hirotomo Tanaka Selected Research

RNA (Ribonucleic Acid)

2/2013

MicroRNA-183 upregulates HIF-1α by targeting isocitrate dehydrogenase 2 (IDH2) in glioma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hirotomo Tanaka Research Topics

Disease

11	Neoplasms (Cancer) 03/2024 - 01/2010
6	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 05/2013
4	Lymphoma (Lymphomas) 09/2023 - 03/2012
3	Glioma (Gliomas) 10/2019 - 02/2013
3	Brain Neoplasms (Brain Tumor) 08/2018 - 01/2010
2	Aneurysm (Aneurysms) 01/2023 - 08/2014
2	Pathologic Constriction (Stenosis) 10/2021 - 09/2021
2	Neoplasm Metastasis (Metastasis) 04/2019 - 01/2010
1	Graves Ophthalmopathy 03/2024
1	Radiation induced meningioma 03/2024
1	Hyperthyroidism 03/2024
1	Meningioma (Meningiomas) 03/2024
1	Facial Paralysis (Facial Palsy) 09/2023
1	Hearing Loss (Hearing Impairment) 09/2023
1	Intracranial Arteriovenous Malformations (Cerebral Arteriovenous Malformation) 01/2023
1	Epilepsy (Aura) 01/2022
1	Stroke (Strokes) 10/2021
1	Paresis (Hemiparesis) 09/2021
1	Starvation 01/2021
1	Medulloblastoma 08/2018
1	Putaminal Hemorrhage 07/2017
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 09/2015
1	Pituitary Neoplasms (Pituitary Adenoma) 08/2014
1	Diplopia (Double Vision) 08/2014
1	Rupture 08/2014
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 08/2014
1	Prolactinoma (Prolactinomas) 08/2014
1	Sarcoma (Soft Tissue Sarcoma) 01/2010

Drug/Important Bio-Agent (IBA)

4	Interleukin-10 (Interleukin 10)IBA 01/2020 - 03/2012
3	Interleukin-6 (Interleukin 6)IBA 10/2019 - 03/2012
3	GadoliniumIBA 08/2018 - 10/2012
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 06/2013 - 02/2013
2	SteroidsIBA 03/2024 - 09/2023
2	Glutamic Acid (Glutamate)FDA Link 01/2022 - 01/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 09/2016
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 03/2012
2	CytokinesIBA 10/2019 - 09/2015
2	MethyltransferasesIBA 06/2013 - 01/2010
2	AcidsIBA 05/2013 - 01/2010
2	Proteins (Proteins, Gene)FDA Link 02/2013 - 01/2010
1	serpentine (alkaloid)IBA 01/2023
1	CreatineIBA 01/2022
1	Glutamine (L-Glutamine)FDA Link 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Bevacizumab (Avastin)FDA Link 01/2021
1	Ketone BodiesIBA 01/2021
1	Aspartic Acid (Aspartate)FDA Link 01/2021
1	Amino Acids FDA Link 01/2021
1	LigandsIBA 01/2020
1	succinyl- interleukin-2IBA 01/2020
1	ChemokinesIBA 01/2020
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 04/2019
1	Natriuretic PeptidesIBA 08/2018
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 09/2016
1	ProlactinIBA 08/2014
1	Cabergoline FDA LinkGeneric 08/2014
1	Lactic Acid (Lactate)FDA LinkGeneric 05/2013
1	isocitric acid (isocitrate)IBA 05/2013
1	alpha-aminopimelic acidIBA 05/2013
1	Small Interfering RNA (siRNA)IBA 02/2013
1	3' Untranslated Regions (3' UTR)IBA 02/2013
1	Messenger RNA (mRNA)IBA 02/2013
1	RNA (Ribonucleic Acid)IBA 02/2013
1	LuciferasesIBA 02/2013
1	Temozolomide (Temodar)FDA LinkGeneric 01/2010

Therapy/Procedure

5	Therapeutics 03/2024 - 08/2014
3	Craniotomy 03/2024 - 08/2014
3	Radiotherapy 03/2024 - 01/2010
2	Drug Therapy (Chemotherapy) 06/2013 - 01/2010
1	Combined Modality Therapy 10/2021
1	Thrombectomy 10/2021
1	Stents 10/2021
1	Carbohydrate-Restricted Diet (Low Carbohydrate Diet) 01/2021
1	Ketogenic Diet 01/2021
1	Aftercare (After-Treatment) 08/2014
1	Chemoradiotherapy 06/2013